Parkinson Disease

Study Finds Patients With Parkinson Disease at Greater Risk of Death by Suicide

December 21st 2020, 5:22pm


Patients with Parkinson disease were shown to be at greater risk of suicide than matched participants in the general population, according to study findings published last week.

Pandemic-Related Social Isolation Linked With Worsening Symptom Severity, Quality of Life in Parkinson Disease

December 19th 2020, 3:00pm


Amid the coronavirus disease 2019 pandemic, patients with Parkinson disease reporting feelings of loneliness were found to experience greater severity of symptoms.

What We’re Reading: Eli Lilly to Buy Prevail Therapeutics; Extra Doses of Pfizer Vaccine; Breast Cancer Drug Approved

December 17th 2020, 3:15pm


Eli Lilly & Co is set to acquire Prevail Therapeutics Inc for almost $1 billion; Pfizer’s coronavirus disease 2019 vaccine vials found to contain extra doses; a new treatment has been approved for patients with advanced breast cancer.

Review Outlines Dermatologic Implications in Parkinson Disease

December 10th 2020, 2:00pm


Researchers review the association between Parkinson disease and dermatologic disorders, as well as implications that this link may have on the pathophysiological mechanisms underlying Parkinson disease.

How Has Neurological Telemedicine Fared Amid COVID-19?

December 8th 2020, 2:30pm


The effectiveness of telemedicine services among patients with neurological conditions was spotlighted amid the coronavirus disease 2019 (COVID-19) pandemic, particularly how telephone and video consultations have fared in temporarily replacing face-to-face consultations.

Technological Innovations, Challenges to Integration in Parkinson Disease Management

December 5th 2020, 3:00pm


Researchers discuss the latest advances in technology-enabled care under development for Parkinson disease, as well as potential challenges to achieve full integration.

How Managed Care Pharmacists Can Improve Current Standards of Treatment for Parkinson Disease

December 1st 2020, 11:06pm


Managed care pharmacists can influence several aspects of care in Parkinson disease, particularly through determining clinical pathways and educating patients and providers on novel agents coming to market.

What Can Alleviate Levodopa-Induced Dyskinesia in Parkinson Disease?

November 27th 2020, 3:00pm


Low-frequency transcranial stimulation of the pre-supplementary motor area was found to delay the onset and reduce severity of levodopa-induced dyskinesia in patients with Parkinson disease.

How an Eye Exam May Improve Early Diagnosis of Parkinson Disease

November 23rd 2020, 8:00pm


An eye exam paired with artificial intelligence machine learning technology may provide a novel approach to diagnose Parkinson disease in early stages.

Dr Patty Taddei-Allen on Therapeutic Advances in Parkinson Disease

November 19th 2020, 10:16pm


In addition to different dosage forms of levodopa—the current standard of care for Parkinson disease—emerging trials are also examining alpha-synuclein, an abnormal protein that may be involved in the pathogenesis of the condition.